Literature DB >> 12513119

Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells.

Shu-Er Chow1, Wing-Keung Chu, Stephen H Shih, Jan-Kan Chen.   

Abstract

Oxidized low-density lipoprotein (ox-LDL) has been shown to alter the migratory and proliferative activities of the vascular endothelial cells (EC) in response to serum and growth factors. The mechanism underlying the antiproliferative effect of ox-LDL on vascular EC has not been fully elucidated. In this report, we show that exposure of vascular EC to ox-LDL results in a marked reduction of the membrane-associated Ras protein. Further study shows that in ox-LDL-treated EC, reduction of the membrane-associated Ras protein is correlated with a reduced amount of active Ras (Ras-guanosine triphosphate), indicating that the Ras signaling pathway is attenuated. The attenuation of the Ras signaling pathway in ox-LDL-treated EC may thus be responsible for the retarded response to the mitogenic stimulation of serum and growth factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12513119     DOI: 10.1290/1071-2690(2002)038<0320:ETOLDL>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  46 in total

1.  Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells.

Authors:  D S Cissel; M A Beaven
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.

Authors:  M E Rosenfeld; R Ross
Journal:  Arteriosclerosis       Date:  1990 Sep-Oct

3.  Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.

Authors:  T B Rajavashisth; A Andalibi; M C Territo; J A Berliner; M Navab; A M Fogelman; A J Lusis
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

4.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

Authors:  S D Cushing; J A Berliner; A J Valente; M C Territo; M Navab; F Parhami; R Gerrity; C J Schwartz; A M Fogelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

Authors:  J R Hessler; A L Robertson; G M Chisolm
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

6.  Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.

Authors:  J A Cuthbert; P E Lipsky
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

7.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

8.  Oxidized LDL ceroid, and prostaglandin metabolism in human atherosclerosis.

Authors:  D A Armstrong
Journal:  Med Hypotheses       Date:  1992-07       Impact factor: 1.538

9.  Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis.

Authors:  J Huang; M Mohammadi; G A Rodrigues; J Schlessinger
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

10.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts.

Authors:  B Björkerud; S Björkerud
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311

View more
  1 in total

1.  Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction.

Authors:  H Farhangkhoee; Z A Khan; Y Barbin; S Chakrabarti
Journal:  Diabetologia       Date:  2005-05-25       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.